✦ LIBER ✦

WHICH PATIENTS WITH T0-4 N0 M0 PROSTATE CANCER NOT SUITABLE FOR LOCAL TREATMENT WITH CURATIVE INTENT DO NOT NEED IMMEDIATE TREATMENT IN EORTC TRIAL 30891?

✍ Scribed by L. Collette; U.E. Studer; P. Whelan; W. Albrecht; J. Casselman; T.M. De Reijke; D. Hauri; W. Loidl; S. Isorna; S.K. Sundaram; M. Debois

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Using PSA to Guide Timing of Androgen De

✍ Urs E. Studer; Laurence Collette; Peter Whelan; Walter Albrecht; Jacques Casselm 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 757 KB

IS THE DEGREE OF PSA DECLINE AFTER IMMED

✍ Collette, L.; Studer, U.E.; Whelan, P.; Albrecht, W.; Casselman, J.; De Reijke, 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 53 KB

303Patients with asymptomatic prostate c

✍ U.E. Studer; P. Whelan; W. Albrecht; J. Casselman; T. De Reijke; D. Hauri; W. Lo 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 206 KB

Immediate or Deferred Androgen Deprivati

✍ Kibel, A.S.; Andriole, G.L. 📂 Article 📅 2007 🏛 Elsevier Science ⚖ 57 KB

Re: Immediate or Deferred Androgen Depri

✍ Cesare Selli 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 52 KB

PSA DOUBLING TIME AS PREDICTOR OF OBJECT

✍ L. Collette; U.E. Studer; P. Whelan; W. Albrecht; J. Casselman; T.M. De Reijke; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 53 KB